Encapsia joins forces with Endpoint
30 Apr 2021
At encapsia, we are pleased to be working with a like-minded partner in endpoint. With both organizations focused on simplifying the user experience and management of complex trials through technology, it was a natural step to integrate our two state-of-the-art technology systems to drive innovation and generate significant efficiencies in the clinical trial space.
With encapsia, site users no longer need to use a separate IRT system – they do all their work in encapsia. Complex IRT tasks like managing randomization, drug supply and inventory management, and drug dispensation can now be performed in real-time using the single interface and unified database of encapsia. This revolutionary advancement frees the site users from the time and complexity of working with multiple systems, bringing operational freedom with cost savings that carry through to the entire clinical study.
“One of several direct data collection (DDC) options within encapsia®, eSource DDC holds significant promise for the industry as a standalone option, but its major benefit is bringing simplicity to the complex clinical trials ecosystem of technology and services. To that end, over 2-and-a-half years ago, we leveraged the dynamic architecture of encapsia with the hyper-integration approach endpoint uses in a joint effort to tightly connect systems into one continuum of experience for the sites and study managers alike,” says Temitope Keyes, Executive Director at Cmed Technology.
“The encapsia and endpoint teams have demonstrated a deep commitment to partnership, client success, technological innovation, and thought leadership in the industry that drives our mutual ability to deliver a highly harmonized set of systems together successfully. We provide an intuitive and seamless solution for clinical supplies and clinical operations workflows, always in compliance while utilizing dynamic data in near-real-time.”
This partnership is part of the ConnectionPOINT program which has the sole mission to nurture a sustainable, scalable infrastructure amongst a network of strong, vetted partnerships in support of eClinical business and technology, predicated on the principles of creating opportunities, driving innovation, and harmonizing delivery across the trials ecosystem.
As the complexity of clinical trials steadily increases, encapsia and endpoint are dedicated to minimizing the burden on site staff and provide them with an optimal “consumer-like” experience.
Other partners in ConnectionPOINT are TSS, a leading global provider of temperature monitoring technology and services and McCreadie Group, provider of innovative web-based software for pharmacy education and clinical drug research.